Family · Pharmaceutical analytical standards
Vildagliptin
A DPP-4 inhibitor (gliptin) for type 2 diabetes: it prolongs the action of incretins, the gut hormones that stimulate insulin release after meals. First synthesised in 1998, it was approved in Europe in 2007. This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?Its molecule contains an adamantane group, a tiny cage of carbon atoms arranged as in diamond: the name in fact comes from the Greek adamantinos.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
